Mapp Biopharmaceutical, Inc.
We develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.
Publications
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody.
Apr 05, 2017
De Novo MS/MS Sequencing of Native Human Antibodies.
Oct 25, 2016
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.
Oct 13, 2016
Monoclonal antibody therapy for Junin virus infection.
Apr 4, 2016
Antibody therapeutics for Ebola virus disease.
January 27, 2016